| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.35 | 2e-18 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.33 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.28 | 2e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.28 | 7e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.28 | 4e-13 |